Last reviewed · How we verify
NCT06855550
Postoperative Incidence of Atrial Fibrillation Following Cardiac Surgery
trial in Atrial Fibrillation (AF) in 435 participants. Completed in 12 December 2022.
3 June 2016
Quick facts
| Lead sponsor | Fundación Cardioinfantil Instituto de Cardiología |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 435 |
| Start date | 4 May 2015 |
| Primary completion | 3 June 2016 |
| Estimated completion | 12 December 2022 |
| Sites | 1 location across Colombia |
Conditions studied
- Atrial Fibrillation (AF) — all drugs for Atrial Fibrillation (AF) →
- Hypomagnesemia — all drugs for Hypomagnesemia →
- Cardiac Surgery — all drugs for Cardiac Surgery →
Sponsor
Fundación Cardioinfantil Instituto de Cardiología — full company profile →
Who can join
18 and older, any sex, with Atrial Fibrillation (AF) or Hypomagnesemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Postoperative atrial fibrillation is one of the most frequent complications in cardiac surgery, with an expected incidence of more than 50% following valve surgery. Hypomagnesemia is also likely to be observed in the postoperative period, and several studies have suggested that it could be related to the incidence of postoperative atrial fibrillation. In this study, via a prospective design and adjustment for multiple covariates, the investigators will seek to determine whether plasma magnesium levels are independently associated with the appearance of postoperative atrial fibrillation. Methods: An analytical design involving a concurrent cohort will be carried out in a high-complexity hospital with a cardiovascular focus. Serial postoperative plasma magnesium measurements will be included as independent variables in a logistic regression model to determine their association with atrial fibrillation after adjusting for multiple covariates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06855550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation (AF)
Currently open trials in the same condition.
- NCT07298473 — Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp · NA · recruiting
- NCT07442175 — Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial · recruiting
- NCT07389434 — Feasibility, Safety, Cost-effectiveness, and Environmental Impact of Reprocessed Ablation Catheters in PVI · NA · recruiting
- NCT07250529 — Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF · NA · recruiting
- NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
Other Fundación Cardioinfantil Instituto de Cardiología trials
Trials by the same sponsor.
- NCT06871293 — Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19 · NA · recruiting
- NCT07035509 — Randomized Control Study in REsuscitation of SEpsis Trial · Phase 4 · not yet recruiting
- NCT06452901 — PROgressive struCturEd Simulation-based Surgical Training Program (PROCESS) - Open Vascular Surgery · NA · not yet recruiting
- NCT05147623 — Colombian Surgical Outcomes Study - COLSOS · unknown
- NCT04604665 — Evaluation of Two Levels of Frequency of Repositioning in the Reduction of Pressure Ulcers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06855550 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Cardioinfantil Instituto de Cardiología
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06855550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing